JOURNAL OF KOREAN MEDICAL SCIENCE《韩国医学科学杂志》（可官网投稿）

杂志简称：j korean med sci
中文译名：《韩国医学科学杂志》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：6.80%
投稿方向：医学、medicine, general & internal 医学、内科

SCI/E期刊基本信息

出版周期：周刊 地区：韩国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：OA期刊
国际标准刊号：ISSN1011-8934；EISSN1598-6357
杂志语言：英语
出版国家：韩国

杂志官网 联系方式

出版地址：7F SAMGU BLDG 40 Cheongpa-ro,Yongsan-gu Seoul 04373,Korea.
杂志邮箱：
投稿网址：https://www.editorialmanager.com/jkms
杂志官方网址：https://jkms.org/
出版商网址：http://jkms.org

杂志投稿要求

投稿须知【杂志社官方网站信息】

Information for Contributors

The Journal of Korean Medical Science (JKMS) is an international, Open Access, peer-reviewed weekly journal of medicine published online only in English. The Journal's publisher is the Korean Academy of Medical Sciences (KAMS). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome. When an article is written in a language other than English and has not been propagated in any international information services (abstract journals), secondary publication of the article is negotiable.

I. MANUSCRIPT SUBMISSION

Authors should submit manuscripts via the electronic manuscript management system for JKMS, https://www.editorialmanager.com/jkms. Please log in first as a member of the system and follow the directions. Manuscripts should be submitted by the corresponding author, who should indicate the address and phone number for correspondence in the title page of the manuscript. If available, a fax number and e-mail address would be helpful. The revised manuscript should be submitted through the same web system under the same identification numbers. Items pertaining to manuscripts submitted for publication, as well as letters or other forms of communication regarding the editorial management of JKMS should be sent to:

Editor-in-Chief

Professor Sung-Tae Hong, MD, PhD

Managing Editor

Professor Jong-Min Kim, MD, PhD

Tel: +82.2-798-3807 (Ext. 5)

Fax: +82.2-794-3148

E-Mail: jkms@kams.or.kr

II. CATEGORIES OF PUBLICATIONS

JKMS publishes editorials, invited review articles, special articles, original articles, case reports, brief communications, opinions, images in this issue, and correspondences.

Editorials are invited perspectives on an area of medical science, dealing with very active fields of research, current medical interests, fresh insights and debates.

Opinions suggest creative perspectives for medical issues.

Images in this issue are classic images of common medical conditions. Images in this issue are not intended as a vehicle for case reports. Images, educational for common medical conditions, would be given priority for publication.

Review articles provide a concise review of a subject of importance to medical researchers written by an invited expert in medical science.

Special articles are invited with an intention of special introduction of medical information.

Original articles are papers reporting the results of basic and clinical investigations that are sufficiently well documented to be acceptable to critical readers.

Case reports deal with clinical cases of medical interest or innovation.

Brief communications are short original research articles on issues important to medical researchers.

Correspondence includes a reader's comment on an article published in JKMS and a reply from the authors.

III. EDITORIAL AND PEER REVIEW PROCESS

JKMS reviews all manuscripts received. A manuscript is previewed for its format and academic relevancy, and then rejected or sent to the 3 most relevant investigators available for review of the contents. The editor selects peer referees by recommendation of the Editorial Board members or from the Board's specialist database. In addition, if deemed necessary, a review of statistics may be requested.

Acceptance of the manuscript is decided based on the critiques and recommended decision of the referees. A referee may recommend "accept", " minor revision", "major revision," or "reject". If there is a marked discrepancy in the decisions between two referees or between the opinions of the author and referee(s), the Editor may send the manuscript to another referee for additional comments and a recommended decision. Three repeated decisions of "major revision" are regarded as a “rejection.” The reviewed manuscripts are returned back to the corresponding author with comments and recommended revisions. Names and decisions of the referees are masked. A final editor's decision on acceptance or rejection for publication is forwarded to the corresponding author from the Editorial Office.

The usual reasons for rejection are topics that are too specific and target audience that is too limited, insufficient originality, serious scientific flaws, poor quality of illustrations, or absence of a message that might be important to readers. Rarity of a disease condition is itself not an acceptable justification for a case report. The peer review process takes usually four to eight weeks after the manuscript submission.

Revisions are usually requested to take account of criticisms and comments made by referees. The revised manuscript should be resubmitted via the web system. Failure to resubmit the revised manuscript within 2 months without any notice from the corresponding author is regarded as a withdrawal. The corresponding author must indicate clearly what alterations have been made in response to the referee's comments point by point. Acceptable reasons should be given for noncompliance with any recommendation of the referees.

IV. EDITORIAL POLICY

The Editor assumes that all authors listed in a manuscript have agreed with the following policy of JKMS on submission of manuscripts. Preprinted manuscripts in medRxiv, bioRxiv or similar platforms are allowed to submit to the Journal. But manuscripts published in other journals will not be considered for publication except for negotiated secondary publication. Under any circumstances, the identities of the referees will not be revealed.

If a new author should be added or an author should be deleted after the submission, it is the responsibility of the corresponding author to ensure that the authors concerned are aware of and agree to the change in authorship. JKMS has no responsibility for such changes.

Minimum article processing charges are due for every accepted manuscript. All published manuscripts become the permanent property of the KAMS and may not be published elsewhere without written permission.

V. ETHICAL CONSIDERATIONS

Research Ethics

All of the manuscripts should be prepared based on strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/), World Association of Medical Editors (WAME, http://www.wame.org/), and the Korean Association of Medical Journal Editors (KAMJE, http://www.kamje.or.kr/intro.php?body=eng-index). All studies involving human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB). Please refer to the principles embodied in the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) for all investigations involving human materials. Animal experiments also should be reviewed by an appropriate committee (IACUC) for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee (IBC). The approval should be described in the Methods section. For studies of humans including case reports, state whether informed consents were obtained from the study participants. The editor of JKMS may request submission of copies of informed consents from human subjects in clinical studies or IRB approval documents. The JKMS will follow the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org/) for settlement of any misconduct.

Conflict of Interest

The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest possibly influencing the research or interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may include financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems. Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (https://jkms.org/src/coi-disclosure.docx). The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a study should be explicitly stated. The JKMS asks referees to let its Editor know of any conflict of interest before reviewing a particular manuscript.

Authorship

The JKMS follows the recommendations for authorship by the ICMJE, 2019 (http://www.icmje.org/icmje-recommendations.pdf) and Good Publication Practice Guidelines for Medical Journals 3rd Edition (KAMJE, 2019, https://www.kamje.or.kr/board/view?b-name=bo-publication&bo-id=13&per-page=). Authorship credit should be based on 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; 2) Drafting the work or revising it critically for important intellectual content; 3) Final approval of the version to be published; and 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions of 1, 2, 3, and 4. In addition, an author should be accountable for the parts of the work he or she has done and should be able to identify which co-authors are responsible for specific other parts of the work. Authors should have confidence in the integrity of the contributions of their coauthors. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged as contributors not be authors. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.

A corresponding author should be designated when there are two or more authors. The corresponding author is primarily responsible for all issues to the editor and audience. Any comment of the corresponding author is regarded as opinion of all coauthors.

When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.

Redundant Publication and Plagiarism

Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s)”. Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (b) “the subjects or study populations are the same or overlapped,” (c) “the methodology is typically identical or nearly so,” and (d) “the results and their interpretation generally vary little, if at all.”

When submitting a manuscript, authors should include a letter informing the editor of any potential overlap with other already published material or material being evaluated for publication and should also state how the manuscript submitted to JKMS differs substantially from other materials. If all or part of your patient population was previously reported, this should be mentioned in the Methods, with citation of the appropriate reference(s).

Clinical Trials

Obligation to register

Clinical trial defined as “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome” should be registered to the primary registry to be prior publication. JKMS accepts the registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (http://www.who.int/ictrp/en/), NIH ClinicalTrials.gov (http://www.clinicaltrials.gov/), ISRCTN Resister (www.ISRCTN.org), or the Clinical Research Information Service (CRIS), Korea CDC (https://cris.hih.go.kr/cris/index.jsp). The clinical trial registration number shall be published at the end of the abstract.

Data sharing statement

JKMS accepts the ICMJE Recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results should submit a data sharing statement following the ICMJE guidelines from 1 July 2018. Authors may refer to the editorial, “Data Sharing statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors,” in JKMS Vol. 32, No. 7:1051-1053 (http://crossmark.crossref.org/dialog/?doi=10.3346/jkms.2017.32.7.1051&domain=pdf&date-stamp=2017-06-05).

VI. MANUSCRIPT PREPARATION AND FORMAT

Authorship

JKMS accepts authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE).

Original Articles

Manuscript Style

The manuscript should be prepared according to the “ICMJE Recommendations for the Conducts, Reporting, and Publication of Scholarly Work in Medical Journals” (2019) (http://www.icmje.org). In addition to the ICMJE recommendation, a number of reporting guidelines have been developed by groups of experts to facilitate reporting of research studies or clinical trials (http://www.equator-network.org/library/). For reporting of randomized controlled trials, JKMS requires compliance with the statement of CONSORT (http://www.consort-statement.org/) and the ICMJE Statement on Data Sharing (http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration).

Manuscript Components

All materials must be written in proper and clear English. The manuscript including tables and their footnotes, and figure legends, must be typed in one double space. Materials should be prepared with a standard 11-point font. The manuscript should be in the following sequence: title page, abstract and key words, introduction, methods, results, discussion, acknowledgments, disclosure, author contribution, ORCID iDs, references, figure legends, and tables. All pages should be numbered consecutively starting from the title page. All numbers should be written in Arabic numerals throughout the manuscripts except for the first word of a sentence. Figures should not be inserted in the main text. A combined figure file or individual figure files can be uploaded your figures separately from the main text file.

File Formats

Our preferred file type for new manuscript submissions is Microsoft Office Word (DOC). We will also accept WordPerfect (.WPD), and text (.TXT) documents or (.RTF) file format. For submission of drawings, photos, graphs, or combined figures, PPT and PDF formats are acceptable. We cannot accept graphic files other than the two programs. It is permissible to send low-resolution images for peer review, but we will ask for high-resolution files later. Acceptable file formats for video are .mov, .wmv, .mpg, .mpeg, or .mp4. The file size and running time of each video should be no more than 25 MB and 5 minutes, respectively.

Title Page:

The title page should contain the title of an article, full names of authors with their ORCID iDs, and institutional affiliation(s). If several authors and institutions are listed, it should be clearly indicated with which department and institution each author is affiliated by using superscript numbers in sequence. Information on corresponding author, including full name, academic degree, address (institutional affiliation, city, zip code, and country), and email address, should be given in a separate paragraph. Funding sources should be informed as a footnote in the title page. The running title should consist of no more than 8 words.

Abstract and Keywords:

The abstract should briefly describe the content of the manuscript in a structured format. The abstract should be structured as follows; Background, Methods, Results, and Conclusion. In principle, acronym and informal abbreviation should be avoided, but they, if needed, can be kept to an absolute minimum with proper identifications. Three to six keywords should be listed at the end on the Abstract page. For the selection of keywords, refer to Medical Subject Headings (MeSH) in PubMed, or at the internet site, http://www.nlm.nih.gov/mesh/MBrowser.html.

INTRODUCTION:

A brief background, references to the most pertinent papers general enough to inform readers, and the relevant findings of others should be included. It is recommended that the introduction includes ‘general and specific background’, ‘debating issue’, and ‘specific purpose of this study’.